PMDA drug package insert
アスピー点鼻薬ＥＸａ＜季節性アレルギー専用＞
PMDA OTC drug · アスゲン製薬株式会社 · package insert Dec 28, 2020
Key facts
| Brand names | アスピー点鼻薬ＥＸａ＜季節性アレルギー専用＞ |
|---|---|
| Companies | 製造販売元／株式会社雪の元本店,販売会社／アスゲン製薬株式会社 |
| Product type | OTC drug |
| OTC risk class | 第「２」類医薬品 |
| OTC dosage form | 噴霧剤 |
| OTC effect category | 鼻炎用点鼻薬 |
| Package insert date | Dec 28, 2020 |
| PMDA document key | 820021_K2011000028 |
| PMDA company code | 820021 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: